Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-12-01
|
| Series: | JAAD Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512623003533 |
| _version_ | 1797389473503248384 |
|---|---|
| author | Warner Robinson, DDS Beth N. McLellan, MD |
| author_facet | Warner Robinson, DDS Beth N. McLellan, MD |
| author_sort | Warner Robinson, DDS |
| collection | DOAJ |
| first_indexed | 2024-03-08T22:56:28Z |
| format | Article |
| id | doaj.art-64e264c7af0248079afc40a45b480e9b |
| institution | Directory Open Access Journal |
| issn | 2352-5126 |
| language | English |
| last_indexed | 2024-03-08T22:56:28Z |
| publishDate | 2023-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | JAAD Case Reports |
| spelling | doaj.art-64e264c7af0248079afc40a45b480e9b2023-12-16T06:07:49ZengElsevierJAAD Case Reports2352-51262023-12-01423134Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritusWarner Robinson, DDS0Beth N. McLellan, MD1Division of Dermatology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New YorkCorrespondence to: Beth N. McLellan, MD, Division of Dermatology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York.; Division of Dermatology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New Yorkhttp://www.sciencedirect.com/science/article/pii/S2352512623003533checkpoint inhibitordupilumabDupixentPD-1 inhibitorvitiligo |
| spellingShingle | Warner Robinson, DDS Beth N. McLellan, MD Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus JAAD Case Reports checkpoint inhibitor dupilumab Dupixent PD-1 inhibitor vitiligo |
| title | Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus |
| title_full | Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus |
| title_fullStr | Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus |
| title_full_unstemmed | Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus |
| title_short | Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus |
| title_sort | incidental improvement of programmed cell death 1 receptor inhibitor induced vitiligo after initiation of dupilumab therapy for refractory pruritus |
| topic | checkpoint inhibitor dupilumab Dupixent PD-1 inhibitor vitiligo |
| url | http://www.sciencedirect.com/science/article/pii/S2352512623003533 |
| work_keys_str_mv | AT warnerrobinsondds incidentalimprovementofprogrammedcelldeath1receptorinhibitorinducedvitiligoafterinitiationofdupilumabtherapyforrefractorypruritus AT bethnmclellanmd incidentalimprovementofprogrammedcelldeath1receptorinhibitorinducedvitiligoafterinitiationofdupilumabtherapyforrefractorypruritus |